EUVIMEDEUVIMED entdecken
MetaanalyseSystematische ÜbersichtOpen Access · CC BY 4.0

DOAC Score Versus HAS‐BLED and ORBIT for Predicting Bleeding Events in Atrial Fibrillation on Direct Oral Anticoagulants

Yanfei Guo, Wengen Zhu iD, Qunfeng Ren

Clinical Cardiology · 2026-05 · 49 (5)

DOI: 10.1002/clc.70315 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift Clinical Cardiology, online erschienen am 27.04.2026. Verfasst von Yanfei Guo und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Medicine, The First People's Hospital of Chenzhou, The First Affiliated Hospital of Xiangnan University, Xiangnan Univer…. Hauptthemen laut MEDLINE: Atrial Fibrillation, Hemorrhage, Anticoagulants, Stroke. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Hunan Province Regional Joint Fund, Project of Health Commission of Hunan Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The comparative performance of the DOAC score versus established bleeding risk scores in patients with atrial fibrillation (AF) receiving direct oral anticoagulants (DOACs) remains uncertain. This meta‐analysis evaluated the predictive ability of the DOAC score compared with HAS‐BLED and ORBIT.

Methods

PubMed and Embase were systematically searched to identify studies assessing the predictive performance of the DOAC score in AF patients treated with DOACs. Pooled C‐indices were calculated to compare discrimination. Reclassification metrics (net reclassification improvement [NRI], integrated discrimination improvement [IDI]), calibration analyses, and decision curve analyses (DCA) were synthesized qualitatively.

Results

Nine studies comprising 12 cohorts were included ( n = 89 688). The DOAC score demonstrated significantly superior discrimination for major bleeding compared with HAS‐BLED (C‐index 0.68 vs. 0.63). No significant differences were observed for intracranial hemorrhage, gastrointestinal bleeding, or clinically relevant non‐major bleeding, nor in comparisons with ORBIT. Reclassification analyses showed heterogeneous findings, with several studies reporting no incremental benefit of the DOAC score, although one large cohort demonstrated improved NRI and IDI over HAS‐BLED. Calibration analyses revealed good performance across scores, though both HAS‐BLED and DOAC tended to overestimate bleeding risk in high‐risk groups. DCA suggested variable but occasionally greater net benefit of the DOAC score at clinically relevant risk thresholds.

Conclusions

The DOAC score provides modest but statistically significant improvement in predicting major bleeding compared with HAS‐BLED, with comparable performance to ORBIT. However, reclassification, calibration, and clinical utility vary across settings, underscoring the need for further prospective validation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial FibrillationHemorrhageAnticoagulantsStrokeHumansAdministration, OralRisk AssessmentRisk FactorsPredictive Value of Tests

Stichwörter der Autor:innen

DOAC scoreatrial fibrillationbleeding riskdirect oral anticoagulants

Substanzen

Anticoagulants

Autor:innen und Institutionen

  • Department of Cardiovascular Medicine, The First People's Hospital of Chenzhou, The First Affiliated Hospital of Xiangnan University, Xiangnan University, Chenzhou, Hunan, People's Republic of China.
  • Department of Cardiology, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, People's Republic of China.
  • Department of Critical Care Medicine, The First People's Hospital of Chenzhou, The First Affiliated Hospital of Xiangnan University, Xiangnan University, Chenzhou, Hunan, People's Republic of China.

ORCID-Profile: Wengen Zhu

Förderung

  • Natural Science Foundation of Hunan Province Regional Joint Fund
  • Project of Health Commission of Hunan Province

Zitieren

APA

Guo, Y., Zhu, W., & Ren, Q. (2026). DOAC Score Versus HAS‐BLED and ORBIT for Predicting Bleeding Events in Atrial Fibrillation on Direct Oral Anticoagulants. Clinical Cardiology, 49(5). https://doi.org/10.1002/clc.70315

Vancouver

Guo Y, Zhu W, Ren Q. DOAC Score Versus HAS‐BLED and ORBIT for Predicting Bleeding Events in Atrial Fibrillation on Direct Oral Anticoagulants. Clinical Cardiology. 2026;49(5). doi:10.1002/clc.70315

BibTeX
@article{Guo2026,
  author = {Guo, Yanfei and Zhu, Wengen and Ren, Qunfeng},
  title = {DOAC Score Versus HAS‐BLED and ORBIT for Predicting Bleeding Events in Atrial Fibrillation on Direct Oral Anticoagulants},
  journal = {Clinical Cardiology},
  year = {2026},
  volume = {49},
  number = {5},
  doi = {10.1002/clc.70315}
}
Kostenlos starten →